Cargando…

Il-1r1 drives leukemogenesis induced by Tet2 loss

Detalles Bibliográficos
Autores principales:	Burns, Sarah S., Kumar, Ramesh, Pasupuleti, Santhosh Kumar, So, Kaman, Zhang, Chi, Kapur, Reuben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522579/ https://www.ncbi.nlm.nih.gov/pubmed/35962058 http://dx.doi.org/10.1038/s41375-022-01665-3

Ejemplares similares

Combined heterozygosity of FLT3(ITD), TET2, and DNMT3A results in aggressive leukemia
por: Ramdas, Baskar, et al.
Publicado: (2022)

TET2 deficiency promotes MDS-associated leukemogenesis
por: Huang, Feiteng, et al.
Publicado: (2022)

Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models
por: Ono, Ryoichi, et al.
Publicado: (2021)

Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis
por: Rasmussen, Kasper D., et al.
Publicado: (2015)

Correction: TET2 deficiency promotes MDS-associated leukemogenesis
por: Huang, Feiteng, et al.
Publicado: (2023)

Driver Mutations in Leukemia Promote Disease Pathogenesis through a Combination of Cell-Autonomous and Niche Modulation
por: Ramdas, Baskar, et al.
Publicado: (2020)

Aging drives Tet2(+/−) clonal hematopoiesis via IL-1 signaling
por: Caiado, Francisco, et al.
Publicado: (2023)

Promoter Strength Driving TetR Determines the Regulatory Properties of Tet-Controlled Expression Systems
por: Georgi, Christiane, et al.
Publicado: (2012)

The Role of TAL1 in Hematopoiesis and Leukemogenesis
por: Vagapova, E. R., et al.
Publicado: (2018)

NSD1 in erythroid differentiation and leukemogenesis
por: Tauchmann, Samantha, et al.
Publicado: (2020)

Coordinated Alterations in RNA Splicing and Epigenetic Regulation Drive Leukemogenesis
por: Yoshimi, Akihide, et al.
Publicado: (2019)

The process of leukemogenesis.
por: Irons, R D, et al.
Publicado: (1996)

The SQSTM1-NUP214 fusion protein interacts with Crm1, activates Hoxa and Meis1 genes, and drives leukemogenesis in mice
por: Lavau, Catherine P., et al.
Publicado: (2020)

Mosaic loss of chromosome Y promotes leukemogenesis and clonal hematopoiesis
por: Zhang, Qi, et al.
Publicado: (2022)

Quaking and miR-155 interactions in inflammation and leukemogenesis
por: Tili, Esmerina, et al.
Publicado: (2015)

Loss of Dnmt3a impairs hematopoietic homeostasis and myeloid cell skewing via the PI3Kinase pathway
por: Palam, Lakshmi Reddy, et al.
Publicado: (2023)

A cohesive look at leukemogenesis: The cohesin complex and other driving mutations in AML
por: Heimbruch, Katelyn E., et al.
Publicado: (2021)

The Philadelphia chromosome in leukemogenesis
por: Kang, Zhi-Jie, et al.
Publicado: (2016)

Immunity drives TET1 regulation in cancer through NF-κB
por: Collignon, Evelyne, et al.
Publicado: (2018)

Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML)
por: Steinhäuser, Sophie, et al.
Publicado: (2022)

The Histone Methyltransferase Activity of MLL1 Is Dispensable for Hematopoiesis and Leukemogenesis
por: Mishra, Bibhu P., et al.
Publicado: (2014)

MLL1/WDR5 complex in leukemogenesis and epigenetic regulation
por: Wu, Min, et al.
Publicado: (2011)

Leukemogenesis and ageing: ‘fit for transformation’ ?
por: Greaves, Mel
Publicado: (2011)

The mutual regulatory loop between TPTEP1 and miR-1303 in leukemogenesis of acute myeloid leukemia
por: Li, Li, et al.
Publicado: (2021)

TAF1 plays a critical role in AML1-ETO driven leukemogenesis
por: Xu, Ye, et al.
Publicado: (2019)

Mir142 loss unlocks IDH2(R140)-dependent leukemogenesis through antagonistic regulation of HOX genes
por: Marshall, A., et al.
Publicado: (2020)

Loss of TET2 and TET3 in regulatory T cells unleashes effector function
por: Yue, Xiaojing, et al.
Publicado: (2019)

TET2 and TET3 loss disrupts small intestine differentiation and homeostasis
por: Ansari, Ihab, et al.
Publicado: (2023)

Physioxia-induced downregulation of Tet2 in hematopoietic stem cells contributes to enhanced self-renewal
por: Aljoufi, Arafat, et al.
Publicado: (2022)

Nup98 regulation of histone methylation promotes normal gene expression and may drive leukemogenesis
por: Sump, Bethany, et al.
Publicado: (2017)

Endogenous epitope-tagging of Tet1, Tet2 and Tet3 identifies TET2 as a naïve pluripotency marker
por: Pantier, Raphaël, et al.
Publicado: (2019)

Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination
por: Cakouros, Dimitrios, et al.
Publicado: (2019)

A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis
por: Shen, Na, et al.
Publicado: (2014)

Heterodimerization of AML1/ETO with CBFβ is required for leukemogenesis but not for myeloproliferation
por: Thiel, V N, et al.
Publicado: (2017)

B1 oligomerization regulates PML nuclear body biogenesis and leukemogenesis
por: Li, Yuwen, et al.
Publicado: (2019)

Meis1 supports leukemogenesis through stimulation of ribosomal biogenesis and Myc
por: Garcia-Cuellar, Maria-Paz, et al.
Publicado: (2022)

SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation
por: Cusan, Martina, et al.
Publicado: (2023)

Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential
por: Burns, Sarah S., et al.
Publicado: (2020)

Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia
por: Burns, Sarah S., et al.
Publicado: (2020)

Granulocyte colony-stimulating factor and leukemogenesis.
por: de Figueiredo, Lorena Lobo, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_dfpru3a114kgeg63b58ufg2rms